Consumer Analyst / Channel Surveillance Specialist, India Independent Insight

Pranav Bhavsar

Consumer Analyst / Channel Surveillance Specialist

India Independent Insight

India Independent Insight (Iii), is a collaborative initiative by Nitin Mangal and Pranav Bhavsar. Nitin Mangal is a SEBI registered Independent Analyst (SEBI Reg. INH 000004723) and Pranav Bhavsar is a SEBI registered Investment Advisor (SEBI Reg. INA 000011510). With Iii our endeavor is to deliver Independent & Unbiased research on Indian Mid to large cap companies. Iii typically provides counter consensus views which cover forensic research along with on-ground primary research. Our research process is a combination of a deep dive on accounting, governance and channel checks.

Equity Bottom-Up

<ul>
<li>In this Insight, we review the recent performance of <a href="https://www.smartkarma.com/entities/abb-india-ltd" target="_blank" data-smartkarma-citation="entities:8703:1" rel="noopener">ABB India Ltd (ABB IN)</a> , <a href="https://www.smartkarma.com/entities/siemens-ltd" target="_blank" data-smartkarma-citation="entities:6440:1" rel="noopener">Siemens Ltd (SIEM IN)</a> , <a href="https://www.smartkarma.com/entities/polycab-india-ltd" target="_blank" data-smartkarma-citation="entities:27877:1" rel="noopener">Polycab India (POLYCAB IN)</a> and <a href="https://www.smartkarma.com/entities/havells-india-ltd" target="_blank" data-smartkarma-citation="entities:9158:1" rel="noopener">Havells India (HAVL IN)</a>. </li>
<li>ABB posted a strong start, SIEM has a black dot with respect to its recent sale of subsidiary. POLYCAB continues to perform, and HAVL is back to capex mode. </li>
<li>Our picks remain the same, ABB instead of SIEM, POLYCAB instead of HAVL.</li>
</ul>


In this Insight, we review the recent performance of ABB India Ltd (ABB IN) , Siemens Ltd (SIEM IN) , Polycab India (POLYCAB IN) and Havells India (HAVL IN). 
ABB posted a strong start, SIEM has a black dot with respect to its recent sale of subsidiary. POLYCAB continues to perform, and HAVL is back to capex mode. 
Our picks remain the same, ABB instead of SIEM, POLYCAB instead of HAVL.


India Industrials | Quarterly Update - ABB, SIEM, HAVELLS, POLYCAB

External broker reports(aggregated public sources), Axis Direct

Axis Direct

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

<ul><li>AIL reported revenue growth of 7.0% YoY in Q4FY23 (vs. our expectations of 10.7% YoY), which stood below the IPM growth of 11.0% (IPM: Indian Pharma Industry, Source: AIOCD).</li><li>A product mix change, higher proportion towards Anti Diabetic segment, Mixtard and Novomix reported growth of 4.0% and -1.1% on YoY respctively led to lower topline growth.</li><li>Further, growth in other key therapies like Gasteroinsteinal (+11.4% YoY) and Hormones (+27.4% YoY) similar to IPM growth.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

AIL reported revenue growth of 7.0% YoY in Q4FY23 (vs. our expectations of 10.7% YoY), which stood below the IPM growth of 11.0% (IPM: Indian Pharma Industry, Source: AIOCD).A product mix change, higher proportion towards Anti Diabetic segment, Mixtard and Novomix reported growth of 4.0% and -1.1% on YoY respctively led to lower topline growth.Further, growth in other key therapies like Gasteroinsteinal (+11.4% YoY) and Hormones (+27.4% YoY) similar to IPM growth.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Abbott India Ltd - Missed on Topline Growth

<ul><li>The IPM industry grew by 12% while AIL reported Q2FY22 growth of 8.3% YoY.</li><li>The growth was majorly driven by the sales improvement in key therapies such as Gasteroinsteinal (+12% YoY) and Hormones (+17% YoY).</li><li>EBITDA margins improved by 187bps due to other expenses falling by 370bps.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

The IPM industry grew by 12% while AIL reported Q2FY22 growth of 8.3% YoY.The growth was majorly driven by the sales improvement in key therapies such as Gasteroinsteinal (+12% YoY) and Hormones (+17% YoY).EBITDA margins improved by 187bps due to other expenses falling by 370bps.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Abbott India Ltd - Strong Operating Profitability

External broker reports(aggregated public sources), ICICI Securities Ltd

ICICI Securities Limited

ICICI Securities Ltd

ICICI Securities Limited provides investment services. The Company provides corporate and investment banking, securities, wealth management, retail brokerage, initial public offerings, and advisory services. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

<ul><li>ABB India (ABB) is a leader in technology solutions connecting software to its electrification, robotics, automation and motion portfolio.</li><li>It operates in mainly three key segments including robotics &amp; motion (41%), electrification (38%), industrial/ process automation (22%)</li><li>Well placed to gain from the overall energy market transformation from electrification to automation &amp; digitization.</li></ul>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

ABB India (ABB) is a leader in technology solutions connecting software to its electrification, robotics, automation and motion portfolio.It operates in mainly three key segments including robotics &amp; motion (41%), electrification (38%), industrial/ process automation (22%)Well placed to gain from the overall energy market transformation from electrification to automation &amp; digitization.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

ABB India (ABB) - Positive Performance Continues…

<ul>
<li>In this Insight, we review the recent performance of <a href="https://www.smartkarma.com/entities/abb-india-ltd" target="_blank" data-smartkarma-citation="entities:8703:1" rel="noopener">ABB India Ltd (ABB IN)</a>, <a href="https://www.smartkarma.com/entities/siemens-ltd" target="_blank" data-smartkarma-citation="entities:6440:1" rel="noopener">Siemens Ltd (SIEM IN)</a>, <a href="https://www.smartkarma.com/entities/polycab-india-ltd" target="_blank" data-smartkarma-citation="entities:27877:1" rel="noopener">Polycab India (POLYCAB IN)</a> and <a href="https://www.smartkarma.com/entities/havells-india-ltd" target="_blank" data-smartkarma-citation="entities:9158:1" rel="noopener">Havells India (HAVL IN)</a> </li>
<li>Most companies have performed in line with our expectations, except for Polycab, which has exceeded our performance expectations.</li>
<li>We continue to favour ABB over Siemens (ABB/SIEM), Polycab over Havells (POLYCAB/HAVL)</li>
</ul>


In this Insight, we review the recent performance of ABB India Ltd (ABB IN), Siemens Ltd (SIEM IN), Polycab India (POLYCAB IN) and Havells India (HAVL IN) 
Most companies have performed in line with our expectations, except for Polycab, which has exceeded our performance expectations.
We continue to favour ABB over Siemens (ABB/SIEM), Polycab over Havells (POLYCAB/HAVL)


India Industrials | Quarterly Update - ABB India, Siemens, Polycab and Havells

India

ABB India Limited undertakes engineering and construction projects and manufactures heavy engineering and industrial equipment. The Company undertakes projects in the field of energy production, power transmission, transportation, process automation and pollution control. ABB India's products include pollution control equipment, switch gears and high current rectifiers.

52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

ABB India Ltd (ABB IN)

India Industrials | Quarterly Update - ABB, SIEM, HAVELLS, POLYCAB

ABB strong, SIEM's subsidiary sale a concern. POLYCAB performing, HAVL in capex mode. Picks: ABB over SIEM, POLYCAB over HAVL.

Pranav Bhavsar

Abbott India Ltd - Missed on Topline Growth

AIL reported revenue growth of 7.0% YoY in Q4FY23 (vs. our expectations of 10.7% YoY), which stood below the IPM growth of 11.0% (IPM: Indian...

Axis Direct

Abbott India Ltd - Strong Operating Profitability

The growth was majorly driven by the sales improvement in key therapies such as Gasteroinsteinal (+12% YoY) and Hormones (+17% YoY).

Axis Direct

ABB India (ABB) - Positive Performance Continues…

ABB India (ABB) is a leader in technology solutions connecting software to its electrification, robotics, automation and motion portfolio.

ICICI Securities Limited

India Industrials | Quarterly Update - ABB India, Siemens, Polycab and Havells

In this analysis, we assess ABB IN, SIEM IN, POLYCAB IN, and HAVL IN. Most are on par with expectations, except Polycab, which exceeded them. Our...

Pranav Bhavsar

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)